Pages that link to "Q33370478"

The following pages link to Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile (Q33370478):

Displaying 31 items.

• Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells (Q26744724) (← links)
• Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats (Q28249695) (← links)
• Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma (Q33691241) (← links)
• Characterization of the colchicine binding site on avian tubulin isotype betaVI. (Q33780549) (← links)
• J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox(™) Safety and Genotoxicity Analysis (Q34433111) (← links)
• Natural products as leads to anticancer drugs (Q34730142) (← links)
• Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors (Q35074386) (← links)
• Assessment of anti-cytogenotoxic effects of quercetin in animals treated with topotecan (Q35185625) (← links)
• Apoptosis of human gastric cancer SGC-7901 cells induced by podophyllotoxin (Q35190172) (← links)
• A novel topoisomerase inhibitor, daurinol, suppresses growth of HCT116 cells with low hematological toxicity compared to etoposide (Q35571888) (← links)
• Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse (Q36065491) (← links)
• The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice (Q36379560) (← links)
• Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung Cancer (Q36394224) (← links)
• Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers (Q37427240) (← links)
• Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents (Q37437603) (← links)
• Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study (Q37441604) (← links)
• Addition of propolis to irinotecan therapy prolongs survival in ehrlich ascites tumor-bearing mice. (Q37593205) (← links)
• Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development (Q38088759) (← links)
• Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide (Q38185496) (← links)
• Plant species forbidden in health food and their toxic constituents, toxicology and detoxification (Q38671002) (← links)
• Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect (Q38810615) (← links)
• Investigation and Expression of the Secoisolariciresinol Dehydrogenase Gene Involved in Podophyllotoxin Biosynthesis. (Q38972693) (← links)
• Cytotoxic podophyllotoxin type-lignans from the steam bark of Bursera fagaroides var. fagaroides (Q39300092) (← links)
• The role of biotechnology in the production of the anticancer compound podophyllotoxin. (Q45971707) (← links)
• Molecular cytogenetic evaluation of the mechanism of micronuclei formation induced by camptothecin, topotecan, and irinotecan (Q46157830) (← links)
• Chronic myeloid leukemia following the treatment of rectal adenocarcinoma (Q46676910) (← links)
• Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia. (Q51458897) (← links)
• Involvement of multidrug resistance-associated protein 1 in intestinal toxicity of methotrexate. (Q51767832) (← links)
• Pinoresinol-lariciresinol reductase: Substrate versatility, enantiospecificity, and kinetic properties (Q90580944) (← links)
• TLC388 Induces DNA Damage and G2 Phase Cell Cycle Arrest in Human Non-Small Cell Lung Cancer Cells (Q91850463) (← links)
• Design, Synthesis and Cancer Cell Growth Inhibition Evaluation of New Aminoquinone Hybrid Molecules (Q92733185) (← links)